What's new

ARPANSA has released a draft advisory note on the public health considerations for disposal of radioactive waste.

The Australian Radiation Protection and Nuclear Safety Agency has partnered with the Republic of the Marshall Islands (RMI) government to support the development of a sovereign radiation monitoring capability in the region.

On 29 June 2018, the ARPANSA CEO issued a Direction to ANSTO to initiate an independent safety review following a series of events with safety implications at the ANSTO Health (now Health Products) facility. ARPANSA has been monitoring progress against the implementation plan and is generally satisfied with the actions taken to date.

The annual report of the CEO of ARPANSA 2020-2021 was tabled in parliament on Tuesday 19 October 2021 and is now available in the Commonwealth government Transparency Portal.

The Australian Nuclear Science and Technology Organisation (ANSTO), one of ARPANSA’s major licence holders, has submitted an application to increase temporary storage of radioactive waste at their Lucas Heights site. ARPANSA will host a consultation forum on Wednesday 13 October.

ARPANSA has published updated diagnostic reference levels for medical imaging. These reference levels help clinics understand typical radiation doses received during medical imaging.

ARPANSA has launched a new research framework to facilitate research of electromagnetic energy exposures and health.

The ARPANSA and the Australian Dental Association (ADA) have joined together to produce a factsheet for patients to explain different types of dental imaging and the associated levels of radiation exposure. 

The International Commission on Radiological Protection (ICRP) has commenced a review of its System of Radiological Protection. The System provides recommendations for protection of people and the environment from the harmful effects of ionising radiation.

In celebration of National Science Week 2021 (14-22 August), ARPANSA will be hosting an online event ‘Mobile phones and health’, with our Electromagnetic Energy (EME) Program Director, Associate Professor Sarah Loughran.

ARPANSA is pleased to be collaborating with Monash University to support a PhD opportunity to investigate injuries from cosmetic use of non-ionising radiation.

Recruitment is currently underway for the next Chief Executive Officer (CEO) of the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA).

ARPANSA is proud to announce that our Chief Radiation Health Scientist and Deputy CEO, Dr Gillian Hirth, has been appointed to the Main Commission of the International Commission on Radiological Protection (ICRP) for the term 2021-2025.

Recent tests conducted at the Bureau International des Poids et Mesures (BIPM) in Paris have confirmed that the Australian Primary Standard for ionising radiation, which underpins every radiotherapy treatment for cancer in Australia, remains accurate and in-line with international standards.

ARPANSA works with international bodies to share knowledge and develop best practice radiation protection and nuclear safety through regulation.

A study conducted by the Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) and the University of Auckland has found no link between mobile phone use and salivary gland cancers.

International academic journal, Radiation Protection Dosimetry, has announced that ARPANSA’s 2017 research paper ‘Exposure to Radiofrequency Electromagnetic Field from Wi-fi in Australian schools’, is one of the five most-read articles in the journal’s history.

Every day, humans are exposed to radiation. From natural radiation sources such as minerals in the ground to artificial sources such as receiving an X-ray for medical purposes, we receive doses of radiation from a variety of sources.